Lymphocyte-to-C-reactive protein ratio predicts prognosis in unresectable locally advanced non-small cell lung cancer patients

Background The lymphocyte-to-C-reactive protein ratio (LCR) is a promising inflammation-based tool for assessing the status of patients with malignant tumours. This study evaluated the ability of LCR to predict the prognosis of patients with unresectable locally advanced non-small cell lung cancer (...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingying Xu, Jinping Li, Xiang Ji, Qingqing Chen, Zhengcao Liu, Shengjun Ji
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2487629
Tags: Add Tag
No Tags, Be the first to tag this record!